Evidence map›Paper›PMID 32765528›Full record

ReviewFrontiers in immunology2020

Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope.

Chi Li, Howard Donninger, John Eaton, Kavitha Yaddanapudi

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Microbial Extracellular Vesicles in Host-Microbiota Interactions.Results and problems in cell differentiation · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Exosome application in tumorigenesis: diagnosis and treatment of melanoma.Medical oncology (Northwood, London, England) · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chi LiExperimental Therapeutics Group, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, United States.
Howard DonningerExperimental Therapeutics Group, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, United States.
John EatonDepartment of Medicine, University of Louisville, Louisville, KY, United States.
Kavitha YaddanapudiImmuno-Oncology Group, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, United States.
University of Louisville · US

Funding

Activating Bax as a therapeutic strategy for lung cancerR01CA175003 · NCI · UNIVERSITY OF LOUISVILLE · PI LI, CHI · 2013 to 2017
$1.5M
A Novel Vaccination Stratagem for Lung CancerR21CA198249 · NCI · UNIVERSITY OF LOUISVILLE · PI YADDANAPUDI, KAVITHA · 2015 to 2016
$359k
NCI NIH HHS R01 CA175003NCI NIH HHS R21 CA198249
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are a heterogenous group of membrane-surrounded structures. Besides serving as a harbor for the unwanted material exocytosed by cells, EVs play a critical role in conveying intact protein, genetic, and lipid contents that are important for intercellular communication. EVs, broadly comprised of microvesicles and exosomes, are released to the extracellular environment from nearly all cells either via shedding from the plasma membrane or by originating from the endosomal system. Exosomes are 40-150 nm, endosome-derived small EVs (sEVs) that are released by cells into the extracellular environment. This review focuses on the biological properties of immune cell-derived sEVs, including composition and cellular targeting and mechanisms by which these immune cell-derived sEVs influence tumor immunity either by suppressing or promoting tumor growth, are discussed. The final section of this review discusses how the biological properties of immune cell-derived sEVs can be manipulated to improve their immunogenicity.

Indexed as

ImmunomodulationAnimalsBioengineeringCell CommunicationCell-Derived MicroparticlesCell FractionationCell MembraneDisease SusceptibilityExosomesExtracellular VesiclesHumansImmune SystemNeoplasmscancerexosomesextracellular vesiclesimmune cellsimmune suppressionimmunotherapynanovesicles

Identifiers

PMID32765528
PMCPMC7378739
OpenAlexW3042472044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.